Monopar Therapeutics Inc.
MNPR
$80.13
-$2.43-2.94%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -2.39% | -9.40% | 900.19% | -15.43% | -19.04% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -5.02% | 563.62% | 59.07% | -18.69% | -48.74% |
Total Current Assets | -2.41% | -8.65% | 893.31% | -15.46% | -19.44% |
|
|||||
Total Current Assets | -2.41% | -8.65% | 893.31% | -15.46% | -19.44% |
Net Property, Plant & Equipment | 1,198.90% | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -2.21% | -8.63% | 893.31% | -15.46% | -19.44% |
|
|||||
Total Accounts Payable | 3.90% | -33.82% | 100.76% | 3.07% | -24.09% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 6.14% | -71.60% | 367.92% | 3.07% | -24.09% |
|
|||||
Total Current Liabilities | 6.14% | -71.60% | 367.92% | 3.07% | -24.09% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 11.53% | -71.60% | 367.92% | 3.07% | -24.09% |
|
|||||
Common Stock & APIC | 0.73% | 0.95% | 87.32% | 0.26% | 0.47% |
Retained Earnings | -3.13% | -3.46% | -16.84% | -2.05% | -2.77% |
Treasury Stock & Other | 455.96% | -160.56% | 427.27% | -232.53% | 97.62% |
Total Common Equity | -2.60% | -2.62% | 1,012.57% | -18.78% | -18.55% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.60% | -2.62% | 1,012.57% | -18.78% | -18.55% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.60% | -2.62% | 1,012.57% | -18.78% | -18.55% |
|